Dlx4 is a member of a family of homeobox genes with homology to Drosophila distal-less (dll) gene. We show that Dlx4 expression pattern partially overlaps with its cis-linked gene Dlx3 during mouse development as well as in neonatal and adult skin. In mice, Dlx4 is expressed in the branchial arches, embryonic limbs, digits, nose, hair follicle and in the basal and suprabasal layers of mouse interfollicular epidermis. We show that inactivation of Dlx4 in mice did not result in any overtly gross pathology. Skin development, homeostasis and response to TPA treatment were similar in mice with loss of Dlx4 compared to wild-type counterparts.
| BACKG ROU N D
The DLX family of homeobox genes is a group of transcription factors that control cellular patterning and differentiation during development. [1] [2] [3] In human and mouse, the DLX family is comprised of 6 members, which have homology to Drosophila distal-less (dll)
gene. [1] [2] [3] The 6 paralog genes are organized as bigene clusters as Dlx1-Dlx2, Dlx3-Dlx4 and Dlx5-Dlx6. [1] [2] [3] Sequence and expression comparisons show Dlx1-Dlx2 and Dlx5-Dlx6 as closely related clusters with Dlx3-Dlx4 being the most divergent pair. [4] Targeted inactivation of Dlx1, Dlx2, Dlx5 and Dlx6 demonstrated their role in craniofacial, limb and skeletal development. [1, 5, 6] While deletion of Dlx3 function resulted in embryonic lethality at E9.5 of development due to placental failure, [7] epidermal-specific deletion of Dlx3 in mice resulted in skin, teeth and hair follicle abnormalities. [8] [9] [10] [11] [12] [13] The expression of Dlx4 during development has been characterized, yet its function in early mouse development and adulthood has not been determined. [4, 14] Here, we report that genetic ablation of Dlx4 does not overtly affect mouse development, nor does it alter skin formation and homeostasis.
| QUE S TIONS ADDRE SS ED
In this study, we examined Dlx4 deletion in mouse development.
DLX3, which is a cis-linked gene of Dlx4, is actively expressed in the hair follicle, the differentiating epidermal layers of skin, and has an important regulatory role in hair development and keratinocyte differentiation and maintenance of skin barrier function. [8] [9] [10] Therefore, we specifically investigated the consequences of Dlx4 deletion in mouse skin.
| E XPERIMENTAL DE S I G N
See Supporting Information (Appendix S1).
| RE SULTS

| Loss of Dlx4 does not lead to major developmental defects
We generated a Dlx4 knockout mouse model (hereafter called Dlx4 KO) by recombining the β-galactosidase gene into the exon 2 of the Dlx4 locus ( Figure 1A ). The excision of exon 2 was validated by PCR ( Figure 1B ). In mice heterozygous for Dlx4, we detected β-galactosidase activity in branchial arches, limb bones, nose and digits ( Figure 1C ), confirming previously reported sites of Dlx4 expression during development. [3, 4, 14] Dlx4 KO mice were healthy and did not exhibit any overt altered phenotype when compared to wildtype littermates ( Figure S1A ). In addition, skeletal staining at E18.5
did not reveal any defects in bone ( Figure S1B ).
| Dlx4 deletion does not alter epidermal differentiation or hair follicle development
While DLX3 expression is predominant in the suprabasal layers of the epidermis and in the hair matrix, [8] [9] [10] [11] DLX4 expression was observed in all layers of the epidermis as well as in hair matrix and dermal papilla ( Figure 1D ). Western blot analysis also confirms the presence of DLX4 in both basal and suprabasal epidermal layers ( Figure 1E ).
Deletion of Dlx4 was confirmed both at the mRNA ( Figure 1F 
| DLX4 is dispensable for keratinocyte proliferation and migration
DLX4 is overexpressed in a wide variety of cancer types such as leukaemias and in lung, breast, ovarian and prostate cancers. [15] [16] [17] [18] [19] To determine if there is a correlation between ablation of DLX4 function and the proliferative capacity of keratinocytes, we evaluated proliferation and migration. Absence of DLX4 did not affect the proliferation of cultured keratinocytes ( Figure 2A ), and no significant difference in Pcna expression levels though RNA sequencing (RNAseq) was observed at P1 stage of WT and Dlx4 KO ( Figure S4A ).
However, a detectable increase in PCNA-positive cells was seen in DLX4 KO epidermis and hair follicles ( Figure S4B ). Migration of keratinocytes cultured in low and high calcium medium was not affected upon DLX4 deletion in presence or absence mitomycin C treatment ( Figure 2B ). 
| Dlx4 deletion does not significantly alter skin transcriptome or response to TPA treatment
Based on the absence of any overt phenotypic changes in skin of Dlx4 KO mice, we performed RNA-seq analysis to identify at the molecular level, genes and pathways globally affected by Dlx4 deletion.
RNA-seq reads mapped against the mouse genome confirmed total absence of second and third exons of Dlx4 in KO skin ( Figure 2C ). No significant changes were detected at the transcriptome level in Dlx4 KO skin (no q-values below 0.05) ( Figure 2D ).
We previously reported that epidermal Dlx3 deletion results in hyperproliferation, which is exacerbated with TPA treatment. [10] We tested the effect of TPA treatment on DLX4 KO skin and detected no difference between WT and Dlx4 KO as assessed by morphology and quantification of epidermal thickness ( Figure 2E ,F).
| CON CLUS IONS
In summary, our results indicate that while DLX4 expression is observed in both neonatal and adult murine skin, DLX4 function is dispensable for keratinocyte proliferation, differentiation and migration. Dlx4 KO mice were phenotypically indistinguishable from wild-type counterparts, and skin transcriptome analysis did not determine any significant differentially expressed genes linked to the Dlx4 deletion. Indeed, there are mouse lines with knockouts for genes such as Calm4, periplakin, desmoyokin and TMEM45A, which are highly expressed in skin and yet present no overt skin phenotype. [20] [21] [22] [23] Lack of major phenotypic changes in Dlx4 KO mice suggests a non-essential function in skin development and homeostasis, although its role in more challenging conditions such as exposure to UV-B, injury or microbial infection remains to be determined.
However, DLX4 overexpression has been associated with aggressiveness of tumors. Therefore, overexpression of DLX4 in mouse will be important to study in future investigations. [15, 16, 24, 25] Recently, a mutation in DLX4 has been also shown to be associated with human orofacial clefting, with an identified single nucleotide deletion c.546_546delG in the DLX4 gene. [26] Mutations in the cis-linked gene DLX3 are associated with the tricho-dento-osseous (TDO) ectodermal dysplasia. [27] The mutant TDO has a dominant negative function over the WT DLX3. [28] Functionally, genetic mutations that lead to frame shifts or altered amino acid composition present a deleterious effect. Introducing the specific mutation associated with orofacial clefting in the DLX4 gene of mouse may give us a better understanding of DLX4 broader function during development. Zaal from the Light Imaging Section for assistance and input relating to the proliferation and migration assay using IncuCyte.
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